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Inactivation of Raf-1 by a Protein-tyrosine Phosphatase Stimulated
by GTP and Reconstituted by Gai/o Subunits*
(Received for publication, November 22, 1995, and in revised form, December 18, 1995)

Paul Dent‡§¶i, Dean B. Reardon‡§¶‡‡, Steven L. Wood‡§¶, Margaret A. Lindorfer**,
Stephen G. Graberii, James C. Garrison**, David L. Brautigan§¶§§, and Thomas W. Sturgill‡§¶**¶¶
From the ‡Howard Hughes Medical Institute, the §Markey Center for Cell Signaling, and the Departments of ¶Medicine,
§§Microbiology, and **Pharmacology, University of Virginia, Charlottesville, Virginia 22908 and the **iiDepartment of
Pharmacology, West Virginia University, Morgantown, West Virginia 26506

A membrane-associated form of Raf-1 in v-Ras transformed NIH 3T3 cells can be inactivated by protein phosphatases regulated by GTP. Herein, a distinct protein-tyrosine phosphatase (PTPase) in membrane
preparations from v-Ras transformed NIH 3T3 cells was
found to be activated by guanyl-5*-yl imidodiphosphate
(GMPPNP) and was identified as an effector for pertussis toxin (PTx)-sensitive G-protein a subunits. PTPase
activation was blocked by prior treatment of cells with
PTx. PTPase activation by GTP, but not GMPPNP, was
transient. A GMPPNP-stimulated PTPase (PTPase-G)
co-purified with Gai/o subunits during Superose 6 and
Mono Q chromatography. PTPase-G activity in Superose
6 fractions from GDP-treated membranes was reconstituted by activated Gai/o, but not Gbg, subunits. PTPase-G
may contribute to GMPPNP-stimulated inactivation of
Raf-1 in v-Ras cell membranes because Raf-1 inactivation was PTx-sensitive and PTPase-G inactivated exogenous Raf-1.

Raf-1 is a protein serine/threonine kinase that functions
downstream of Ras in the MAP1 kinase cascade, phosphorylating and activating mitogen-activated protein kinase kinase
(MKK or MEK) (reviewed in Ref. 1). The mechanism of Raf-1
activation and inactivation is incompletely understood. Raf-1
activation occurs at the plasma membrane following binding to
Ras-GTP (2, 3). Activation of Raf-1 in vitro by a mixture of
membranes from v-Ras transformed and v-Src transformed
fibroblasts requires ATP/Mg, compatible with a requirement
for phosphorylation of Raf-1 for enzymatic activation (4). Raf-1
becomes phosphorylated on tyrosine and serine residues and
activated upon co-expression with Ras and Src in Sf9 cells
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The abbreviations used are: MAP kinase, mitogen-activated protein
kinase (also known as ERK (extracellular signal-regulated kinase));
PTPase, protein-tyrosine phosphatase; GMPPNP, guanyl-59-yl imidodiphosphate; GTPgS, guanosine 59-O-(3-thiotriphosphate); 2-ME,
2-mercaptoethanol; MEK, MAP kinase/ERK kinase; BSA, bovine serum
albumin; K52R, kinase-defective p42mapk; RCM, reduced, carboxymethylated, and maleylated; Ptx, pertussis toxin; PTPase-G, GMPPNPstimulated PTPase.

(reviewed in Ref. 4) or NIH 3T3 cells (5). Both tyrosine and
serine phosphorylation of Raf-1 appear to be required for Raf-1
activation because Raf-1 isolated from Sf9 cells also expressing
Ras alone2 or Ras and SrcY527F (6) can be inactivated in vitro by
treatment with either protein-serine/threonine or -tyrosine
phosphatases.
Membranes from mammalian cells transformed with oncogenic Ras contain a portion of cellular Raf-1 in a constitutively
active form (7). This membrane-associated form of Raf-1 can be
inactivated by protein phosphatases regulated directly or indirectly by GTP (6). We performed experiments to characterize
the protein phosphatase responsible for GTP-stimulated inactivation of Raf-1 and to define the mechanism of its regulation.
EXPERIMENTAL PROCEDURES

Materials—Guanine nucleotides were purchased from Boehringer
Mannheim. NIH 3T3 cells transformed with Ha-Ras (G12V) were obtained from Dr. L. Feig (Tufts University, Boston, MA). Antibodies to
G-protein subunits were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). PTx was a generous gift from Dr. E Hewlett (University of Virginia). The sources of other reagents have been described
(4, 6).
Membrane Preparations—Membranes were isolated (4 °C) from cells
using the procedures described (4) and resuspended to 1 mg/ml total
protein in buffer A (25 mM HEPES, pH 7.6, 10 mM EDTA, 10 mM EGTA,
0.2% (v/v) 2-ME) containing 8.6% (w/v) sucrose and protease inhibitors
(4).
Guanine Nucleotide-stimulated Inactivation of Endogenous Raf-1—
Membranes (50 mg of total protein) were mixed (53 ml, final volume)
with the indicated nucleotides (5 mM, final) in the presence or absence
of protein phosphatase inhibitors (0.2 mM vanadate, 25 mM b-glycerol
phosphate, 5 mM microcystin-LR (final concentrations)) and left on ice
for 30 min. Samples were incubated (10 min, 30 °C) and then assayed
(30 °C) for Raf-1 activity by sequential additions of: (i) 45 ml of buffer B
(55 mM b-glycerol phosphate, pH 7.4, 40 mM MgCl2, 2.5 mM MnCl2, 0.25
mM vanadate, 2.5 mM microcystin-LR, 0.45 mM g-[32P]ATP (5 cpm/fmol))
for 5 min; (ii) 3 ml of 1 mg/ml (His)6-MEK for 15 min; (iii) 20 ml of 0.1
mg/ml p42mapk K52R for 2 min. Reactions were quenched, and 32P
incorporation into K52R gel bands was determined by Cerenkov
radiation.
Activation of PTPase in Membranes—Membranes (100 mg in 100 ml of
resuspension buffer) were incubated (106 ml, final volume) for 30 min on
ice with 5 mM GTP, GMPPNP, or GDP in Ultraclear (Beckman) tubes.3
MgCl2 was added to samples (2 mM final concentration in excess of
chelators). Membranes were immediately pelleted (100,000 3 g, 10 min,
4 °C) in an Airfuge (Beckman) and resuspended with 100 ml of buffer C
(25 mM HEPES, pH 7.4, 0.1 mM EGTA, 1 mM MgCl2, 0.2% (v/v) 2-ME,
1 mg/ml BSA). PTPase activity was assayed by incubating (30 °C)
portions of sample (0.5–2 ml) with 3 ml of [[32P]Tyr]RCM-lysozyme (8)
(40 pmol of protein Tyr-32PO22
4 ) in buffer C (20 ml total assay volume).

2
Jelinek, T., Dent, P., Sturgill, T. W., and Weber, M. J., Mol. Cell.
Biol., in press.
3
Conditions for loading membranes with guanine nucleotides used
herein were modeled after conditions for loading Ras with GTP and
have not been opitimized for heterotrimeric G-proteins.
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TABLE I
PTx blocks guanine nucleotide-stimulated inactivation of Raf-1 in
membranes from v-Ras cells
32

P incorporated into K52R MAP kinasea

Without PTx treatment

With PTx treatment

PPase inhibitors
2
1
2
1
C
100
93 6 12.7
100
109.5 6 0.7
b
GTP
11.5 6 7.8
87 6 7.0 103 6 11.3 96.5 6 13.5
GMPPNP
16.5 6 10.1b
87 6 2.8
99 6 1.4
97.5 6 10.6
GDP
97 6 11.3 87.5 6 9.2
99 6 4.2 106.5 6 3.5
a
NIH 3T3 cells transformed with Ha-Ras (G12V) were treated with
PTx (100 ng/ml, 20 h) or left untreated (control) prior to isolation of
membranes. Portions of membranes were incubated in the presence or
absence of protein phosphatase (PPase) inhibitors, and Raf activity was
determined by MEK-stimulated phosphorylation of p42mapk-K52R (see
“Experimental Procedures”). Data are expressed as the percentage of
32
P incorporation for samples incubated without guanine nucleotides
and PPase inhibitors (controls (100%): untreated membranes 5 17,016
6 318 cpm; PTx-treated membranes 5 16,729 6 243 cpm; n 5 4; (mean
6 S.D.).
b
p , 0.01.

Reactions were terminated by sequential additions of 200 ml of cold 20%
(w/v) trichloroacetic acid and 10 ml of 10 mg/ml BSA with mixing.
Samples were centrifuged, and 210-ml supernatants were counted in
scintillant. Data were expressed as percentage release of total 32P in the
assay.
Characterization of GMPPNP-stimulated PTPase after Solubilization and Chromatography—Membranes (200 mg of total protein) were
incubated for 30 min on ice with 2 mM (final concentration) GMPPNP or
GDP, adjusted to 2 mM MgCl2 in excess of chelators with a concentrated
stock, and then solubilized by addition of 25 ml of 10% (v/v) Triton X-100
with gentle trituration. Supernatant was recovered after centrifugation
(as above), and 200 ml (representing ;80 –90% of the sample) was
chromatographed (4 °C, 0.25 ml/min, 0.25-ml fractions) on a Superose 6
HR 10/30 column (Pharmacia Biotech Inc.) equilibrated in buffer D (25
mM HEPES, pH 7.4, 2 mM MgCl2, 0.1 mM EGTA, 0.1 mM EDTA, 10%
(v/v) glycerol, 0.01% (v/v) Triton X-100, 0.2% (v/v) 2-ME, 1 mM benzamidine, 1 mM phenylmethylsulfonyl fluoride). Raf-1 deactivation was
assayed (6) by incubation (30 °C, 15 min) of 0.1 mg of active FLAG-Raf-1
(co-expressed with Ras and SrcY527F) with 2 ml of fractions in buffer C
containing 2.4 mM microcystin-LR; Raf-1 activity was measured by
MEK1 phosphorylation. Proteins were precipitated with trichloroacetic
acid (10% w/v, final) for SDS-polyacrylamide gel electrophoresis (11%
gel) and immunoblotting by ECL (Amersham). Where indicated, pooled
fractions were rechromatographed (4 °C, 0.5 ml/min, 1 ml fractions) on
a Mono Q HR 5/5 column (Pharmacia) equilibrated in buffer D. The
column was developed with a linear gradient from 0 –500 mM NaCl in
buffer D.
Reversal of GMPPNP Activation by GDP—Portions (4 ml) of Superose
6 fractions from GMPPNP-treated membranes were treated sequentially on ice by addition of 4 ml of buffer A (15 min) to chelate magnesium and promote dissociation (9) of GMPPNP followed by addition of 4
ml of either 6 mM GMPPNP or GDP containing 30 mM MgCl2 (30 min)
and then assayed for PTPase activity.
Reconstitution with Gai/o Subunits—A mixture of Ga proteins (principally Gai and Gao) were purified from bovine brain and separated into
Gi/o, Ga, and Gbg oligomers by phenyl-Sepharose chromatography essentially as described (10). The resolved Gai/o and Gbg subunits were
pooled separately and concentrated (50 mg/ml) and were .85% pure.
The Gai/o subunit preparation bound GTPgS and was free of Gbg as
assessed by immunoblotting; the Gbg preparation was free of Ga by the
absence of GTPgS binding.4 Baculovirus-expressed Ga subunits were
expressed and purified to near homogeneity essentially as described
(11). Portions of each preparation were incubated on ice (15 min) with
an equal volume of 12 mM guanine nucleotide, 60 mM MgCl2 before use.
RESULTS AND DISCUSSION

Incubation of membranes from v-Ras cells with an antibody
that binds the Ras effector domain did not prevent GMPPNPstimulated inactivation of membrane-associated Raf-1 (6), suggesting involvement of G-proteins other than Ras in Raf-1
inactivation (data not shown). To test for involvement of PTx4

M. A. Lindorfer and J. C. Garrison, unpublished data.

FIG. 1. Activation of a [[32P]Tyr]RCM-lysozyme phosphatase in
isolated membranes by GTP and GMPPNP. Membranes from vRas transformed cells were incubated with GTP (E), GMPPNP (M), or
GDP (●), spiked with Mg21 in excess of chelators, recovered by centrifugation, and portions (0.5 ml) were assayed for PTPase activity at the
times indicated (see “Experimental Procedures”). A, initial PTPase assays. B, assays of samples left for 30 min on ice with periodic mixing.
Dashed line in B, membranes were repelleted and reincubated with
GTP before assay. Representative of 4 experiments.

sensitive heterotrimeric G-proteins, we compared the abilities
of guanine nucleotides to stimulate inactivation of endogenous
Raf-1 in membranes from untreated v-Ras transformed cells in
comparison with membranes from cells that were treated overnight with PTx (Table I). GTP or GMPPNP, but not GDP,
stimulated inactivation of Raf-1 in membranes prepared from
untreated cells, and inactivation was blocked by inclusion of
microcystin-LR and vanadate to inhibit protein-serine/threonine and -tyrosine phosphatases. Raf-1 in membranes prepared
from PTx-treated cells was not susceptible to guanine nucleotide-stimulated inactivation (Table I). PTx specifically catalyzes ADP-ribosylation of a subunits of heterotrimeric G-proteins of the Gi family (except Gz) (reviewed in Ref. 12). Thus,
these results strongly suggested that GTP-stimulated inactivation of Raf-1 in the mixture of membranes from v-Ras cells was
mediated by activation, directly or indirectly, of protein phosphatases by heterotrimeric G-proteins of the Gi family.
Schally and co-workers (13) previously demonstrated that
addition of somatostatin to membranes of pancreatic cancer
cells promoted dephosphorylation of epidermal growth factor
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receptors autophosphorylated on tyrosine, implying activation
of a PTPase by G-protein-coupled receptors. Stork and coworkers (14) extended this observation by demonstrating that
GMPPNP addition to membranes could stimulate a PTPase
activity, assayed using p-nitrophenyl phosphate as substrate,
and that activation of PTPase activity by somatostatin was
PTx-sensitive. Since Raf-1 deactivation was PTx-sensitive (Table I) and a purified PTPase can inactivate Raf-1 in vitro (6), we
hypothesized that a G-protein-activated PTPase might be responsible for guanine nucleotide-stimulated inactivation of
Raf-1.
To test this hypothesis, we determined whether loading of
membranes isolated from v-Ras cells with GTP or GMPPNP
stimulated PTPase activity, using as substrate [[32P]Tyr]RCMlysozyme (Fig. 1). GTP significantly increased the rate of 32P
release in comparison to GDP (Fig. 1A). When membranes were
reassayed after 30 min, the increase in PTPase activity due to
GTP was absent (Fig. 1B, EOOE). Transient activation of
PTPase activity by GTP is consistent with the transient activation of a G-protein a subunit due to timed GTP hydrolysis
(12). Reloading these same membranes with GTP partially
recovered enhanced activity (Fig. 1B, E– – –E), proving that
the decrease in activity was not due simply to protein lability.
GMPPNP, which is not hydrolyzed by Ga subunits, caused a
persistent elevation of PTPase activity (Fig. 1B). Activation
also occurred when 100 mM concentrations of guanine nucleotide were used (data not shown). Neither GTP nor GMPPNP
caused an increase in PTPase activity in membranes from
PTx-treated cells (data not shown). Together, these data demonstrate activation of a [[32P]Tyr]RCM-lysozyme phosphatase
by a PTx-sensitive G-protein.
In parallel experiments, GMPPNP or GTP stimulated
PTPase activity in membranes isolated from parental NIH 3T3
cells with results similar to those in Fig. 1 (data not shown).
Membranes from parental cells, however, contained 5-fold less
GMPPNP-stimulated PTPase activity than membranes from
v-Ras cells (data not shown). Membranes from cells transformed with a different oncogenic Ras, RasQ61L, also showed
significantly increased levels of GMPPNP-stimulated PTPase
activity relative to membranes from parental cells. Thus, the
greater specific activity of GMPPNP-stimulated PTPase is a
consequence of Ras transformation.
The GMPPNP-stimulated PTPase was characterized by gel
permeation chromatography in buffer containing 0.01% (v/v)
Triton X-100 following solubilization of guanine nucleotidetreated membranes with 1% (v/v) detergent. Solubilization per
se increased total PTPase activity 4 –5-fold, but a 2–3-fold stimulation of activity in GMPPNP-treated versus GDP-treated
membranes was preserved (data not shown). The principal
peak of PTPase activity observed with GDP-treated membranes from v-Ras cells eluted between the positions of the
standards bovine g-globulin (150 kDa) and BSA (67 kDa) with
an apparent mass of ;70 kDa (Fig. 2A). Treatment of membranes with GMPPNP reproducibly caused the appearance of a
peak of PTPase activity that eluted earlier, at ;100 kDa (Fig.

FIG. 2. Characterization of PTPase-G by Superose 6 and Mono
Q chromatographies. Membranes from v-Ras transformed NIH 3T3
cells were incubated with GMPPNP (å) or GDP (Ç), solubilized with
Triton X-100, and fractionated for analyses (see “Experimental Proce-

dures”). A and B, portions (2 ml) of fractions were assayed for [[32P]
Tyr]RCM-lysozyme phosphatase activity. B, Raf-1 was treated with
portions (2 ml) of fractions from GMPPNP-treated membranes and
assayed (●) by MEK phosphorylation. Arrows a and b and bar c,
markers for elution of bovine g-globulin, BSA, and soybean trypsin
inhibitor, respectively. C, Immunoblot with anti-Gai/o/t/z antibody C-20
of proteins from GMPPNP-treated membranes in indicated fractions
from Superose 6 chromatography. D, fractions 33 to 39 inclusive were
pooled, subjected to Mono Q chromatography, and assayed for PTPase
activity. E, immunoblot with anti-Gai/o/t/z antibody of proteins from GMPPNP-treated membranes in indicated pairs of pooled fractions from Mono
Q chromatography (D). Data (A–E) are representative of 3 experiments.
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FIG. 3. Regulation of PTPase-G by Gai/o. Membranes from v-Ras
cells were treated with GMPPNP or GDP and fractionated as in Fig. 2A.
A, PTPase activity in portions of fractions from GMPPNP-treated membranes after treatment to substitute GMPPNP (●) or GDP (E) for bound
GMPPNP (see “Experimental Procedures”); Ç, GDP-treated membranes. B, PTPase activity in portions of fractions from GDP-treated
membranes incubated with GMPPNP/Mg brain Gai/o (●), GDP/Mg
brain Gai/o (E), or buffer C (Ç– – –Ç) (see “Experimental Procedures”).
C, PTPase activity in portions of fractions from GDP-treated membranes incubated with 25 ng of activated (see “Experimental Procedures”) recombinant Gao (●), Gai2 (å), Gai1 (f),

2A). We refer herein to this GMPPNP-stimulated PTPase as
PTPase-G. An additional species of GMPPNP-stimulated
PTPase of higher Mr (;150,000) was occasionally observed as
a smaller peak or leading shoulder (data not shown; see also
Fig. 3B). The latter may correspond to a labile PTPase.
We tested whether PTPase-G could deactivate active Raf-1,
using FLAG-Raf-1 purified from Sf9 cells co-expressing Ras
and SrcY527F. A single Gaussian-shaped peak of activity causing deactivation of Raf-1 was detected and corresponded to
PTPase-G (Fig. 2B). The deactivation of Raf-1 occurred in the
presence of 2.4 mM microcystin-LR and was abolished by 0.1 mM
vanadate, consistent with the action of a PTPase (data not
shown). Raf-1 deactivating activity was increased 5–7-fold by
GMPPNP in comparison with GDP (data not shown). Thus,
activation of PTPase-G can explain, at least in part, the ability
of GMPPNP to cause inactivation of endogenous Raf-1 in membranes from v-Ras cells (6).
Our membrane preparations contain membranes derived
from the endoplasmic reticulum in addition to plasma membranes and thus contain PTP1B (15). PTP1B was detected by
immunoblotting (data not shown), and its elution corresponded
to the major peak of [[32P]Tyr]RCM-lysozyme phosphatase activity migrating with an apparent mass of ;70 kDa (centered
at fraction 42) and not to the peak of GMPPNP-stimulated
PTPase (centered at fraction 39). The peak of [[32P]Tyr]RCMlysozyme phosphatase containing 50-kDa PTP1B (Fig. 2B) did
not coincide with deactivation of exogenous Raf-1, suggesting
that PTP1B is not PTPase-G. The COOH-truncated, 37-kDa
form of PTP1B deactivated Raf-1 (6), but this may be due to its
reactivity in vitro at high concentrations or the absence of
regulatory sequences (15).
Using an antibody that recognizes Gai/o/t/z, we detected
Ga subunit(s) in fractions containing GMPPNP-stimulated
PTPase (Fig. 2C). Antibodies C-10 and K-20 to Gai1–3 and Gao
also detected a protein of 41 kDa in these fractions (data not
shown). No Gbg subunits were detected in these fractions by
immunoblotting with antibody T-20 that recognizes Gb1– 4
(data not shown). The profile of the elution of immunoreactive
41-kDa protein correlated well with the profile of GMPPNPstimulated PTPase activity (Fig. 2, compare A and C). Ga
subunits were absent from corresponding fractions in profiles
from GDP-treated membranes, indicating that co-elution of Ga
and PTPase in these fractions required G-protein activation
(data not shown). These results are consistent with activation
of a PTPase by binding of Ga subunits and not Gbg subunits.
Superose 6 fractions encompassing the leading edge of the
PTPase-G peak were pooled to reduce cross-contamination
with the peak of PTP1B and subjected to ion exchange chromatography on Mono Q. PTPase-G was resolved into multiple
forms that eluted in the middle of the gradient (Fig. 2D). The
reasons for this heterogeneity are unknown. Each of these
forms co-eluted with 41-kDa proteins recognized by antibodies
to Gai/o/t/z (Fig. 2E) and also by antibodies to Gai1–3 and Gao
(data not shown). PTP1B eluted in fractions 17–19 and did not
co-elute with a GMPPNP-stimulated peak of PTPase activity or
with Ga subunits. Recovery of PTPase-G activity after Mono Q
chromatography was low, ;20 –30%, which may be indicative
of disruption of a PTPase-G complex.
Reversibility of activation was demonstrated by substitution
of GDP for bound GMPPNP in PTPase-G in fractions from
Superose 6 chromatography (Fig. 3A). Portions of column fractions from GMPPNP-treated membranes were incubated with

or buffer/GMPPNP/Mg (Ç). Data for Gai3 superimposed upon the control
profile and were not plotted. Data are Representative of 2 (C) or 3 (A
and B) experiments.
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GDP or GMPPNP in the presence of Mg chelators to promote
nucleotide dissociation (9) prior to readdition of Mg21 and
assay. Replacement of GMPPNP with GMPPNP preserved the
PTPase-G activity. Replacement of GMPPNP with GDP abolished the peak of PTPase-G, resulting in a profile after reassay
nearly identical with the profile obtained by assay of fractions
from GDP-treated membranes. Since Gbg was not detected in
the fractions containing PTPase activity, reversal of activation
by GDP strongly supports regulation by Ga subunits.
To definitively test this hypothesis, we examined the ability
of purified G-protein subunits to activate PTPase in fractions
from GDP-treated membranes (Fig. 3, B and C). Preparations
of brain Ga and Gbg subunits were utilized to provide a range of
subunits principally derived from members of the Gai family
(10). Addition of brain Ga-GMPPNP, but not brain Ga-GDP,
increased activity of PTPase that eluted in the leading shoulder
of the constitutive ;70-kDa peak of PTPase activity (Fig. 3B).
Brain Ga-GMPPNP also activated a species of Mr ;150,000
that may correspond to the occasionally observed species of
GMPPNP-stimulated PTPase activity noted above. Addition of
a mixture of brain Gbg subunits in the presence of GDP or
GMPPNP did not alter PTPase activity (data not shown). Importantly, addition of activated recombinant Gao, Gai1, and Gai2
also stimulated PTPase activity (Fig. 3C). Gao appeared to
cause a greater activation than Gai1 and Gai2 suggesting specificity in the interaction with the effector PTPase, but detailed
titration studies will be required to determine the relative
potency and efficacy of various PTx-sensitive Ga subunits.
G-protein-coupled receptors may initiate both positive signals for MAP kinase activation via Gbg subunits and negative
signals via Ga subunits, depending on context and the specific
G-protein coupled. For example, epitope-tagged MAP kinase
expressed in Cos-7 cells is transiently activated by isoproterenol via endogenously expressed b-adrenergic receptors (16).
The stimulatory signal is provided by Gbg and is Ras-dependent. An inhibitory signal is provided by Gas-mediated elevation
of cAMP concentration; elevation of cAMP in cells prior to
stimulation blocks MAP kinase activation. In pheromone signaling in Saccharomyces cerevisiae, Ga stimulates an adaptive
pathway that antagonizes Gbg-mediated activation of the MAP
kinase-related enzyme FUS3 (17). The signaling mechanisms
for MAP kinase activation by mammalian G-coupled receptors
are complex (18); it appears that specific Ga subunits may
promote, inhibit, or possibly be indifferent to activation of MAP
kinase by Gbg. Complexity is also indicated by reports that
overexpression of GTPase-impaired Gai2 caused transformation and activation of MAP kinase in Rat-1 but not NIH 3T3
cells (19), and that overexpression of GTPase-impaired Gao
transformed NIH 3T3 cells (20).
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Thus, a balance of positive and negative signals determines
the extent of MAP kinase activation by G-protein-coupled receptors. PTPase-G may deliver a negative signal from receptors
that couple to responsible subtypes of Gai/o to modulate the
timing or extent of activation of MAP kinase. While our experiments reveal a negative modulation by PTPase-G of membrane-associated Raf-1 that has been already activated by vRas, we cannot exclude the possibility that PTPase-G may also
act positively in other contexts or temporal sequences.
Identification of unambiguous effectors for Gai, as well as
Gao, subunits has been elusive (reviewed in Ref. 21). Our findings strongly implicate PTPases as effectors for activated PTxsensitive Ga protein(s), fulfilling each of the classical biochemical criteria utilized to establish adenylate cyclase as an
effector for Gas. Our findings also show that reconstitution with
Gai/o subunits can serve as an assay for purification and identification of PTPase-G. Elucidation of the pathways regulated
by Ga-regulated PTPases should provide insight into the mechanisms of mitogenic signaling and cell cycle control.
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